首页> 美国卫生研究院文献>Emerging Microbes Infections >Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B
【2h】

Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B

机译:进入抑制剂一步中牛磺胆酸钠共转运多肽对HBV转录的上调在进入步骤被抑制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sodium taurocholate cotransporting polypeptide (NTCP) is a functional receptor for hepatitis B virus (HBV) entry. However, little is known regarding whether NTCP is involved in regulating the postentry steps of the HBV life cycle. Here, we found that NTCP expression upregulated HBV transcription at the postentry step and that the NTCP-targeting entry inhibitor Myrcludex B (MyrB) effectively suppressed HBV transcription both in an HBV in vitro infection system and in mice hydrodynamically injected with an HBV expression plasmid. Mechanistically, NTCP upregulated HBV transcription via farnesoid X receptor α (FxRα)-mediated activation of the HBV EN2/core promoter at the postentry step in a manner that was dependent on the bile acid (BA)-transport function of NTCP, which was blocked by MyrB. Our findings uncover a novel role for NTCP in the HBV life cycle and provide a reference for the use of novel NTCP-targeting entry inhibitors to suppress HBV infection and replication.
机译:牛磺胆酸钠共转运多肽(NTCP)是乙型肝炎病毒(HBV)进入的功能受体。但是,对于NTCP是否参与调节HBV生命周期的进入后步骤知之甚少。在这里,我们发现NTCP表达在进入后步骤上调了HBV转录,并且靶向NTCP的进入抑制剂Myrcludex B(MyrB)在HBV体外感染系统和流体动力学注射HBV表达质粒的小鼠中均有效抑制了HBV转录。从机制上讲,NTCP在进入后步骤中通过法呢素X受体α(FxRα)介导的HBV EN2 / core启动子激活来上调HBV转录,其方式取决于NTCP的胆汁酸(BA)转运功能。由MyrB。我们的发现揭示了NTCP在HBV生命周期中的新作用,并为使用新型靶向NTCP的进入抑制剂抑制HBV感染和复制提供了参考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号